Image For Activity Cover
Virtual Tumor Board: Melanoma- June 2021
Treatment options for immunotherapy refractory melanoma
Activity Overview

In this tumor board, the participants will hear a case-based discussion that will include: 

  • Surgical and systemic treatment options for oligometastatic disease and factors that influence decision making towards a systemic therapy or surgical option.
  • Options for patients who present with regional recurrences despite adjuvant systemic therapy.
  • Treatment of in-transit melanoma including intralesional therapies, regional therapies and systemic options.
Moderating this session will be Tina J Hieken, MD, Mayo Clinic


Richard L. White, Jr., MD, FACS, FSSO, Levine Cancer Institute, Atrium Health 
Cristina O'Donoghue, MD, MPH, Rush University
Ryan J. Sullivan, MD, Massachusetts General Hospital

Georgia Beasley, MD, MHSc, Duke University

Availability: No future session
Cost: FREE
Credit Offered:
No Credit Offered
Powered By